Page 1 of 1
Article on Genzyme
Posted: Fri Jul 18, 2008 2:17 am
by bromley
Posted: Fri Jul 18, 2008 5:26 am
by robbie
then failed this spring in a study of patients with the toughest form of MS to treat
what ms are they talking about here?
Posted: Fri Jul 18, 2008 7:20 am
by gibbledygook
Robbie, I think they mean primary progessive MS which recently failed to respond to Rituxan, which depletes B cells. Obviously it's not just B cell inflammation in progressive forms of the disease. Could you enroll in the probiotic/worm trials in Wisconsin? I think they are struggling to recruit. The link is in the General Discussion section.
Posted: Fri Jul 18, 2008 9:12 am
by gwa
gibbledygook wrote: Could you enroll in the probiotic/worm trials in Wisconsin? I think they are struggling to recruit.
Surprise, Surprise!! I bet that they are having a REAL struggle recruiting people.
I imagine that the progressive types are too far gone for this therapy anyway.
gwa
Posted: Fri Jul 18, 2008 1:41 pm
by Terry
The worm one said diagnosed less than 2 years and no CRABS taken, I believe.
That doesn't fit many, does it? Maybe the problem in recruiting is more from that than the wormy thing. That was the criteria for the blood draw I did for Accelerated Cure in March. They were having trouble getting people there, too.
Terry
economics of MS
Posted: Tue Jul 22, 2008 5:37 pm
by k6ristin
What does this say about our healthcare system? This is an excellent article, explaining 2 promising experimental treatments. Yet its focus is really on stock market speculation & big pharma profits!
I use google news set to multiple sclerosis & regularly search for campath articles and had not seen this one. Thank you for posting!
{i received campath 3/08--no obvious miracles but remain hopeful}
Posted: Thu Aug 07, 2008 2:50 pm
by Jamie
To be fair that was a business web site.
But I know what you mean, I have the same alert and it's nearly always stockmarket news.